Effect of ions on inhibition of norepinephrine uptake by angiotensin.
D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D001464:Barium / Q000494:pharmacology; D001920:Bradykinin / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D002247:Carbon Isotopes; D004600:Eledoisin / Q000494:pharmacology; D005934:Glucagon / Q000494:pharmacology; D006168:Guinea Pigs; D006325:Heart Atria; D006352:Heart Ventricles; D066298:In Vitro Techniques; D007609:Kallidin / Q000494:pharmacology; D008168:Lung / Q000378:metabolism; D008274:Magnesium / Q000494:pharmacology; D008345:Manganese / Q000494:pharmacology; D008680:Metaraminol / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000037:antagonists & inhibitors* / Q000378:metabolism; D010042:Ouabain / Q000494:pharmacology; D010121:Oxytocin / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D011817:Rabbits; D012701:Serotonin / Q000378:metabolism; D012964:Sodium / Q000494:pharmacology; D013324:Strontium / Q000494:pharmacology; D014316:Tritium; D014667:Vasopressins / Q000494:pharmacology
D002247:Carbon Isotopes; D014316:Tritium; D014667:Vasopressins; D000804:Angiotensin II; D001464:Barium; D012701:Serotonin; D007609:Kallidin; D008345:Manganese; D010121:Oxytocin; D010042:Ouabain; D004600:Eledoisin; D008680:Metaraminol; D005934:Glucagon; D012964:Sodium; D008274:Magnesium; D011188:Potassium; D001920:Bradykinin; D002118:Calcium; D009638:Norepinephrine; D013324:Strontium